| Entry |
|
|---|
| Name |
Dihydralazine sulfate;
Dihydralazine hydrogen sulfate;
Nepresol (TN) |
|---|
| Formula |
C8H10N6. H2SO4
|
|---|
| Exact mass |
288.0641
|
|---|
| Mol weight |
288.29
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
|
|---|
| Remark |
|
|---|
| Efficacy |
Antihypertensive, Vasodilator (peripheric) |
|---|
| Comment |
Hydrazinophthalazine derivative
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
C02DB Hydrazinophthalazine derivatives
C02DB01 Dihydralazine
D07830 Dihydralazine sulfate
Drug groups [BR:br08330]
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
DG00260 Dihydralazine
D07830 Dihydralazine sulfate
Drug groups [BR:br08330]
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
DG00260 Dihydralazine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C8x C 14.0000 -17.1500
2 C8x C 14.0000 -18.5500
3 C8x C 15.1900 -19.2500
4 C8y C 16.4500 -18.5500
5 C8y C 16.4500 -17.1500
6 C8x C 15.1900 -16.5200
7 C8y C 17.6400 -19.2500
8 N5x N 18.8300 -18.5500
9 N5x N 18.8300 -17.1500
10 C8y C 17.6400 -16.5200
11 N1b N 17.6400 -15.1200
12 N1b N 17.6400 -20.6500
13 N1a N 18.8300 -14.4200
14 N1a N 18.9000 -21.4200
15 S4a S 25.1300 -17.5700
16 O1d O 25.1300 -16.1700
17 O1d O 25.1300 -18.9700
18 O1d O 26.5300 -17.5700
19 O1d O 23.7300 -17.5700
BOND 19
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 5 10 1
12 10 11 1
13 7 12 1
14 11 13 1
15 12 14 1
16 15 16 2
17 15 17 2
18 15 18 1
19 15 19 1
|
|---|
